glp-1 news 2025 november 25 trends 2025: real-world data, patient outcomes & future therapies Harvard Medical School Researcher Wins

Major studies have proven that SGLT2 inhibitors significantly reduce the risk of hospitalization for heart failure and slow the progression of chronic kidney disease

Self-pay patients pay $249 per fill for Wegovy (pill or injectable) with the upfront purchase of a 12-month supply of medication (Medication Commitment)

I think we need to consider that the efficacy of these medications is decreased if they are not taken consistently, and I am curious to see how they perform in real life, Levy said

In many chronic diseases, activation of Nrf2 signaling can also protect cells from ferroptosis

Most protocols use a 12-week course, sometimes longer for best results

Consistent with histological findings, circulating markers of hepatic injury such as ALAT were significantly elevated in the saline group but remained lower in GHRP-6 animals